Pacer Advisors, Inc. Mannkind Corp Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.05 - $5.43 $5,730 - $7,683	-1,415 Reduced 41.52%	1,993 $10,000
Q1 2024 May 10, 2024	BUY	$3.25 - $5.27 $11,076 - $17,960	3,408 New	3,408 $15,000
Q2 2021 Jul 21, 2021	SELL	$3.61 - $5.45 $71,290 - $107,626	-19,748 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$3.14 - $6.14 $28,322 - $55,382	9,020 Added 84.08%	19,748 $77,000
Q4 2020 Jan 20, 2021	BUY	$1.79 - $4.04 $19,203 - $43,341	10,728 New	10,728 $34,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.